hyperlipidaemia. Hypercholesterolaemia with endogenous hyperglyceridaemia
Conditions
Interventions
Intervention 1: Green tea extract 800 mg per day in two capsules after breakfast and dinner. Intervention 2: In two placebo capsules per day after breakfast and dinner.
Treatment - Drugs
Placebo
Green tea extract 800 mg per day in two capsules after breakfast and dinner
In two placebo capsules per day after breakfast and dinner
Sponsors
Ahvaz, Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Over at least one year of normal menstruation; Report one or more of the lipid parameters in the borderline range; Age range 45 to 65 years. Exclusion criteria: Thyroid disorders including Hypothyroidism and Hyperthyroidism, Diabetes, Hypertension, Kidney failure, Liver disease, Coronary artery disease and cancer; Removal of the Gallbladder; A history of Stroke or Heart attack; Consumption of herbal medicines to improve metabolic abnormalities and Hypertension in three months; Following the departure of abnormal uterus and ovaries menopause; Smoking, drugs or Alcohol; Caffeine sensitivity; Use of medications such as Aspirin, female hormones, Lithium, corticosteroids, Warfarin, and supplements containing antioxidants; Non- pharmacological interventions to improve metabolic disorders such as regular exercise, Yoga and acupressure; Regular consumption of Green Tea daily
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Cholesterol. Timepoint: Before the intervention and one month after intervention. Method of measurement: Measurement of serum Total Cholesterol levels after 12 hours of fasting.;Triglycerides. Timepoint: Before the intervention and one month after intervention. Method of measurement: Measurement of serum Triglycerides levels after 12 hours of fasting.;Low Density Lipoprotein (LDL). Timepoint: Before the intervention and one month after intervention. Method of measurement: Measurement of serum Low Density Lipoprotein (LDL) levels after 12 hours of fasting.;High Density Lipoprotein (HDL). Timepoint: Before the intervention and one month after intervention. Method of measurement: Measurement of serum High Density Lipoprotein (HDL) levels after 12 hours of fasting. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Before the intervention, 2 weeks and 4 weeks after intervention. Method of measurement: Medical manometer.;Fasting blood sugar. Timepoint: Before the intervention and one month after intervention. Method of measurement: Measurement of serum Sugar levels after 12 hours of fasting.;Weight. Timepoint: Before the intervention and one month after intervention. Method of measurement: Analog scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamaneh Movahedi zadeh
Ahvaz, Jundishapur University of Medical Sciences
Outcome results
None listed